These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18486039)
21. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs. Rao SS; Raghunathan R; Ekambaram R; Raghunathan M Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168 [TBL] [Abstract][Full Text] [Related]
24. Meropenem-clavulanate: a new strategy for the treatment of tuberculosis? Holzgrabe U ChemMedChem; 2009 Jul; 4(7):1051-3. PubMed ID: 19462395 [TBL] [Abstract][Full Text] [Related]
25. [Study on the antituberculous activity of Tuberactin, a new antibiotic]. Toyohara M Kekkaku; 1968 Jul; 43(7):245-8. PubMed ID: 5727835 [No Abstract] [Full Text] [Related]
29. Biomarkers and surrogate end points in clinical trials of tuberculosis treatment. Davies GR; Phillips PP; Nunn AJ J Infect Dis; 2007 Aug; 196(4):648-9; author reply 649-50. PubMed ID: 17624855 [No Abstract] [Full Text] [Related]
30. [Clinical and experimental data on changes of blood transaminases level during antitubercular antibiotherapy]. Despierres G; Viallier J; Cayre RM Lyon Med; 1967 Dec; 218(51):1629-40. PubMed ID: 5622039 [No Abstract] [Full Text] [Related]
31. [Changes in the biotin and inositol content of tissues of healthy and tubercular guinea pigs during administration of antibacterial preparations]. Kruchakova FA Probl Tuberk; 1970; 48(7):49-54. PubMed ID: 5486082 [No Abstract] [Full Text] [Related]
32. Extensively drug resistance (XDR) tb is not always fatal. Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272 [TBL] [Abstract][Full Text] [Related]
33. Changes in CD4 count with antitubercular therapy in HIV infected children with tuberculosis. Mukherjee A; Lodha R; Kabra SK J Trop Pediatr; 2009 Apr; 55(2):125-7. PubMed ID: 18829637 [No Abstract] [Full Text] [Related]
34. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria]. Robert J; Veziris N; Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875 [No Abstract] [Full Text] [Related]
35. Status report on RNTCP. Chauhan LS Indian J Tuberc; 2009 Jan; 56(1):44-7. PubMed ID: 19402271 [No Abstract] [Full Text] [Related]
36. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment. Showalter HD; Denny WA Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
38. Concurrent ART/TB treatment finally proven to be beneficial. Ryan CT AIDS Clin Care; 2008 Nov; 20(11):89. PubMed ID: 19170252 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M; Bakken V; Gundersen LL Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q; Luo H; Chen Y; Wang T; Yao Q Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]